Cargando…
Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Hemodialysis Patients at Kano Kidney Center
Background Hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) infections are more prevalent in hemodialysis patients compared to the general population. The objective of this study was to evaluate the prevalence of HBV, HCV, and HIV infections in hemodialysis pa...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337696/ https://www.ncbi.nlm.nih.gov/pubmed/37449288 http://dx.doi.org/10.7759/cureus.41769 |
_version_ | 1785071471556558848 |
---|---|
author | Alkhalifah, Ridha H Alhaddad, Mousa J Alhashem, Ali T Alwesaibi, Hussain AlKhalaf, Abdullah A Albin Saad, Abdullah Almattar, Mohammed Alkhalaf, Makarem A Alramadhan, Habib Albaggal, Mohammad |
author_facet | Alkhalifah, Ridha H Alhaddad, Mousa J Alhashem, Ali T Alwesaibi, Hussain AlKhalaf, Abdullah A Albin Saad, Abdullah Almattar, Mohammed Alkhalaf, Makarem A Alramadhan, Habib Albaggal, Mohammad |
author_sort | Alkhalifah, Ridha H |
collection | PubMed |
description | Background Hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) infections are more prevalent in hemodialysis patients compared to the general population. The objective of this study was to evaluate the prevalence of HBV, HCV, and HIV infections in hemodialysis patients dialyzing regularly at Kano Kidney Center (KKC) in the Eastern Health Cluster of Saudi Arabia in 2022. Methods This retrospective study included all hemodialysis patients who were dialyzed regularly at KKC during 2022. Their electronic medical records were reviewed for the results of HBV, HCV, and HIV along with the patient's demographics, comorbid conditions, and dialysis history. The study was approved and monitored by the Institutional Review Board of Dammam Medical Complex. Results A total of 239 regular hemodialysis patients were included, consisting of 142 males and 97 females (59.41% and 40.59%, respectively), with a mean age of 52.71±15.83 years. Most of the patients were Saudis (156 patients, 65.27%) with the non-Saudi patients being composed mostly of Arabian patients. Nine patients (3.77%) tested positive for hepatitis B surface antigen (HBsAg), the serologic hallmark of HBV infection. Two patients (0.84%) had resolved HBV infections as evidenced by positive hepatitis B core antibody (anti-HBc) and hepatitis B surface antibody (anti-HBs). However, the majority (226 patients, 94.56%) were never tested for anti-HBc. Anti-HBs, which can imply long-term immunity against HBV from prior immunizations or infections, were positive in 165 patients (69.04%). A protective anti-HBs level of ≥ 10 IU/L was detected in 158 patients (66.11%) including 104 patients (43.51%) having ≥ 100 IU/L. Eighteen patients (7.53%) had reactive HCV antibodies. Four patients (1.67%) had chronic HCV infection as they had detectable HCV RNA. The remaining 14 patients (5.86%) cleared HCV either spontaneously (seven patients, 2.93%) or by medications (seven patients, 2.93%). HIV screening tests were negative in all 239 patients (100%). HBsAg-positive patients did not have any statistically significant differences from HBsAg-negative patients. On the other hand, the patients who were positive for HCV antibodies were older than the patients who were negative for HCV antibodies (60.66 vs 52.05 years on average, p-value <0.05). They also contained a statistically larger proportion of non-Saudi patients than the patients with no evidence of prior infections (61.11% vs 32.13%, p-value <0.05). Conclusions The study found that the prevalence of HBV and HCV infections among hemodialysis patients in KKC at 3.77% and 1.67%, respectively, is higher than that reported in the general population in Saudi Arabia, with non-Saudis having a higher prevalence rate of HCV infection than Saudis. However, the current prevalence rate is lower compared to the previous studies that were conducted in Saudi Arabia in the first decade of the 21st century, and there were no cases of HIV infections. Nevertheless, a significant proportion of patients had unprotective or negative anti-HBs antibody titers, indicating the need for strict vaccination protocols and monitoring of antibody titers to ensure optimal protection. |
format | Online Article Text |
id | pubmed-10337696 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-103376962023-07-13 Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Hemodialysis Patients at Kano Kidney Center Alkhalifah, Ridha H Alhaddad, Mousa J Alhashem, Ali T Alwesaibi, Hussain AlKhalaf, Abdullah A Albin Saad, Abdullah Almattar, Mohammed Alkhalaf, Makarem A Alramadhan, Habib Albaggal, Mohammad Cureus Gastroenterology Background Hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) infections are more prevalent in hemodialysis patients compared to the general population. The objective of this study was to evaluate the prevalence of HBV, HCV, and HIV infections in hemodialysis patients dialyzing regularly at Kano Kidney Center (KKC) in the Eastern Health Cluster of Saudi Arabia in 2022. Methods This retrospective study included all hemodialysis patients who were dialyzed regularly at KKC during 2022. Their electronic medical records were reviewed for the results of HBV, HCV, and HIV along with the patient's demographics, comorbid conditions, and dialysis history. The study was approved and monitored by the Institutional Review Board of Dammam Medical Complex. Results A total of 239 regular hemodialysis patients were included, consisting of 142 males and 97 females (59.41% and 40.59%, respectively), with a mean age of 52.71±15.83 years. Most of the patients were Saudis (156 patients, 65.27%) with the non-Saudi patients being composed mostly of Arabian patients. Nine patients (3.77%) tested positive for hepatitis B surface antigen (HBsAg), the serologic hallmark of HBV infection. Two patients (0.84%) had resolved HBV infections as evidenced by positive hepatitis B core antibody (anti-HBc) and hepatitis B surface antibody (anti-HBs). However, the majority (226 patients, 94.56%) were never tested for anti-HBc. Anti-HBs, which can imply long-term immunity against HBV from prior immunizations or infections, were positive in 165 patients (69.04%). A protective anti-HBs level of ≥ 10 IU/L was detected in 158 patients (66.11%) including 104 patients (43.51%) having ≥ 100 IU/L. Eighteen patients (7.53%) had reactive HCV antibodies. Four patients (1.67%) had chronic HCV infection as they had detectable HCV RNA. The remaining 14 patients (5.86%) cleared HCV either spontaneously (seven patients, 2.93%) or by medications (seven patients, 2.93%). HIV screening tests were negative in all 239 patients (100%). HBsAg-positive patients did not have any statistically significant differences from HBsAg-negative patients. On the other hand, the patients who were positive for HCV antibodies were older than the patients who were negative for HCV antibodies (60.66 vs 52.05 years on average, p-value <0.05). They also contained a statistically larger proportion of non-Saudi patients than the patients with no evidence of prior infections (61.11% vs 32.13%, p-value <0.05). Conclusions The study found that the prevalence of HBV and HCV infections among hemodialysis patients in KKC at 3.77% and 1.67%, respectively, is higher than that reported in the general population in Saudi Arabia, with non-Saudis having a higher prevalence rate of HCV infection than Saudis. However, the current prevalence rate is lower compared to the previous studies that were conducted in Saudi Arabia in the first decade of the 21st century, and there were no cases of HIV infections. Nevertheless, a significant proportion of patients had unprotective or negative anti-HBs antibody titers, indicating the need for strict vaccination protocols and monitoring of antibody titers to ensure optimal protection. Cureus 2023-07-12 /pmc/articles/PMC10337696/ /pubmed/37449288 http://dx.doi.org/10.7759/cureus.41769 Text en Copyright © 2023, Alkhalifah et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Gastroenterology Alkhalifah, Ridha H Alhaddad, Mousa J Alhashem, Ali T Alwesaibi, Hussain AlKhalaf, Abdullah A Albin Saad, Abdullah Almattar, Mohammed Alkhalaf, Makarem A Alramadhan, Habib Albaggal, Mohammad Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Hemodialysis Patients at Kano Kidney Center |
title | Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Hemodialysis Patients at Kano Kidney Center |
title_full | Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Hemodialysis Patients at Kano Kidney Center |
title_fullStr | Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Hemodialysis Patients at Kano Kidney Center |
title_full_unstemmed | Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Hemodialysis Patients at Kano Kidney Center |
title_short | Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Hemodialysis Patients at Kano Kidney Center |
title_sort | prevalence of hepatitis b virus, hepatitis c virus, and hiv infections in hemodialysis patients at kano kidney center |
topic | Gastroenterology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337696/ https://www.ncbi.nlm.nih.gov/pubmed/37449288 http://dx.doi.org/10.7759/cureus.41769 |
work_keys_str_mv | AT alkhalifahridhah prevalenceofhepatitisbvirushepatitiscvirusandhivinfectionsinhemodialysispatientsatkanokidneycenter AT alhaddadmousaj prevalenceofhepatitisbvirushepatitiscvirusandhivinfectionsinhemodialysispatientsatkanokidneycenter AT alhashemalit prevalenceofhepatitisbvirushepatitiscvirusandhivinfectionsinhemodialysispatientsatkanokidneycenter AT alwesaibihussain prevalenceofhepatitisbvirushepatitiscvirusandhivinfectionsinhemodialysispatientsatkanokidneycenter AT alkhalafabdullaha prevalenceofhepatitisbvirushepatitiscvirusandhivinfectionsinhemodialysispatientsatkanokidneycenter AT albinsaadabdullah prevalenceofhepatitisbvirushepatitiscvirusandhivinfectionsinhemodialysispatientsatkanokidneycenter AT almattarmohammed prevalenceofhepatitisbvirushepatitiscvirusandhivinfectionsinhemodialysispatientsatkanokidneycenter AT alkhalafmakarema prevalenceofhepatitisbvirushepatitiscvirusandhivinfectionsinhemodialysispatientsatkanokidneycenter AT alramadhanhabib prevalenceofhepatitisbvirushepatitiscvirusandhivinfectionsinhemodialysispatientsatkanokidneycenter AT albaggalmohammad prevalenceofhepatitisbvirushepatitiscvirusandhivinfectionsinhemodialysispatientsatkanokidneycenter |